Consumption of caffeinated and decaffeinated coffee enriched with cocoa and fructo-oligosaccharides among non-diabetic persons: Double blind randomized clinical trial.

Publisher: Wiley Country of Publication: United States NLM ID: 7706045 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-4514 (Electronic) Linking ISSN: 01458884 NLM ISO Abbreviation: J Food Biochem Subsets: MEDLINE

Publication: 2008- : Hoboken, NJ : Wiley
Original Publication: Westport, Conn. : Food & Nutrition Press

Cacao* ; Coffee*; Adult ; Blood Glucose ; Blood Pressure ; Caffeine/pharmacology ; Humans ; Oligosaccharides/pharmacology

Food industry has been investing in bringing to the market coffee-based drinks enriched in compounds that promise weight loss, which consequently influences diabetes risk. However, there are no clinical trials showing the effects of brewed coffee (with or without caffeine) enriched with bioactive compounds on body fat and glycemic control in healthy individuals. Therefore, we have evaluated the effect of consuming two coffee formulas enriched with cocoa and fructo-oligosaccharides (FOS) on glycemic and anthropometric biomarkers and blood pressure in non-diabetic adults for 10 weeks. In general, we observed that the values of fasting plasma glucose (FPG) (p = .006) and fasting capillary blood glucose (FCBG) (p < .001) had lower values with a tendency to decrease in FCG (p = .003) and FBG (p < .005) in both formulas. We observed statistically significant reductions in waist circumference (WC) (p = .012), arm circumference (AC) (p = .015), and percentage of fat (<0.0001) for all participants. However, we noticed a greater reduction in the caffeinated formula group (-2.92%, p = .005) compared to the decaffeinated formula (-1.62%, p = .008). Consumers of both cocoa and FOS-enriched coffee formulas benefited from reduced FBG, FCG, WC, and body fat percentage. The consumption of caffeinated formula was more effective in reducing the percentage of fat, while the decaffeinated formula was more effective in reducing diastolic blood pressure. PRACTICAL APPLICATIONS: This study provides robust evidence that effects of fortified coffee on non-diabetic people is positive for reduction in blood glucose, body fat and diastolic blood pressure. This study proposes a practical and safe coffee formulation for the consumption of caffeinated and decaffeinated coffee for non-diabetic people.
(© 2022 Wiley Periodicals LLC.)

American Diabetes Association. (2020). Standards of medical care in diabetes-2012. Statistics about diabetes.
Barengolts, E. (2016). Gut microbiota, prebiotics, probiotics, and synbiotics in management of obesity and prediabetes: Review of randomized controlled trials. Endocrine Practice, 22(10), 1224-1234. https://doi.org/10.4158/EP151157.RA.
Bergman, R. N., Stefanovski, D., Buchanan, T. A., Sumner, A. E., Reynolds, J. C., Sebring, N. G., Xiang, A. H., & Watanabe, R. M. (2011). A better index of body adiposity. Obesity, 19(5), 1083-1089. https://doi.org/10.1038/oby.2011.38.
Bhupathiraju, S. N., Pan, A., Malik, V. S., Manson, J. E., Willett, W. C., Van Dam, R. M., & Hu, F. B. (2014). Caffeinated and caffeine-free beverages and risk of type 2 diabetes. American Journal of Clinical Nutrition, 97(1), 163-174. https://doi.org/10.3945/ajcn.112.048603.
Brucki, S. M. D., Nitrini, R., Caramelli, P., Bertolucciivan, P. H. F., & Okamoto, I. H. (2003). Sugestões para o uso do mini-exame do estado mental no Brasil. Arquivos de Neuro-Psiquiatria, 61(3B), 777-781. https://doi.org/10.1590/S0004-282X2003000500014.
Canela, M. D., Bastos, D. H. M., Pinheiro, M. M., Ciconelli, R. M., FerraZ, M. B., & Martin, L. A.. (2009). Consumption of stimulant drinks and consequent ingestion of phenolic compounds and caffeine. Journal Brazilian of Food, 34, 143-157. http://files.bvs.br/upload/S/1519-8928/2009/v34n1/a143-157pdf.
Carlström, M., & Larsson, S. C. (2018). Coffee consumption and reduced risk of developing type 2 diabetes: A systematic review with meta-analysis. Nutrition Reviews, 76(6), 395-417. https://doi.org/10.1093/nutrit/nuy014.
Cavalcante, J. W. S., Santos, P. M. J., Menezes, M. G. F., Marques, H. O., Cavalcante, L. P., & Pacheco, W. S. (2000). Influência da Cafeína no Comportamento da Pressão Arterial e da Agregação Plaquetária. Arquivos Brasileiros de Cardiologia, 75, 97-101.
Cerdó, T., García-Santos, J. A., Bermúdez, M., & Campoy, C. (2019). The role of probiotics and prebiotics in the prevention and treatment of obesity. Nutrients, 11(3), 635. https://doi.org/10.3390/nu1103063.
Chrysant, S. G. (2017). The impact of coffee consumption on blood pressure, cardiovascular disease and diabetes mellitus. Expert Review of Cardiovascular Therapy, 15(3), 151-156. https://doi.org/10.1080/14779072.2017.1287563.
Cozzolino, F., Lecce, L., Frisullo, P., Conte, A., & Nobile, A. D. (2012). Functional food: Product development and health benefits. Recent Patents on Engineering, 6(1), 2-19. https://doi.org/10.2174/187221212799436763.
Cropley, V., Croft, R., Silber, B., Neale, C., Scholey, A., & Schmitt, J. (2012). Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study. Psychopharmacology (Berl), 219(3), 737-749. https://doi.org/10.1007/s00213-011-2395-0.
Desch, S., Schmidt, J., Kobler, D., Sonnabend, M., Eitel, I., Sareban, M., Rahimi, K., Schuler, G., & Thiele, H. (2010). Effect of cocoa products on blood pressure: Systematic review and meta-analysis. American Journal of Hypertension, 23(1), 97. https://doi.org/10.1038/ajh.2009.213.
Dewar, L., & Heuberger, R. (2017). The effect of acute caffeine intake on insulin sensitivity and glycemic control in people with diabetes. Diabetes & Metabolic Syndrome, 11, S631-S635. https://doi.org/10.1016/j.dsx.2017.04.017.
Encarnação, R. O., & Lima, D. R. (2003). O café e a saúde humana (1st ed.). Embrapa Café. Retrieved January 15, 2021, from http://bbeletronica.sede.embrapa.br/bibweb/bbeletronica/2003/doc/cafe_doc_01.pdf.
Figueiredo, D. M., Pimenta, C. J., Contado, J. L., Paula, M. L., Freitas, R. W. J. F., & Araújo, M. F. M. (2018). The effect of caffeinated and decaffeinated coffee consumption on biochemical and cardiac parameters among brazilians with type 2 diabetes. Journal of Nursing and Health Science, 4, 1-8.
Folstein, M. F., Folstein, S. E., & Mchugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198. https://doi.org/10.1016/0022-3956(75)90026-6.
Grosso, G., Godos, J., Galvano, F., & Giovannucci, E. L. (2017). Coffee, caffeine, and health outcomes: An umbrella review. Annual Review of Nutrition, 37, 131-156. https://doi.org/10.1146/annurev-nutr-071816-064941.
Hauschild, S. D., & Adami, F. S. (2018). Relationship between macronutrients consumption and caffeine with nutritional status and body composition. Revista Brasileira de Obesidade, Nutrição e Emagrecimento, 12, 851-858.
Higashi, Y. (2019). Coffee and endothelial function: A coffee paradox? Nutrients, 11(9), 2104-2125. https://doi.org/10.3390/nu11092104.
Hoffman, J. R., Kang, J., Ratamess, N. A., Jennings, P. F., Mangine, G., & Faigenbaum, A. D. (2006). Thermogenic effect from nutritionally enriched coffee consumption. Journal of the International Society of Sports Nutrition, 3(1), 35-41. https://doi.org/10.1186/1550-2783-3-1-35.
Latham, L. S., Hensen, Z. K., & Minor, D. S. (2014). Chocolate-guilty pleasure or healthy supplement? The Journal of Clinical Hypertension, 16, 101-106. https://doi.org/10.1111/jch.12223.
Latif, R. (2013). Health benefits of cocoa. Current Opinion in Clinical Nutrition and Metabolic Care, 16, 669-674. https://doi.org/10.1097/MCO.0b013e328365a235.
Lima, R. C. A., Júnior, L. C. C., Ferreira, L. L. R., Bezerra, T. L. L., Bezerra, T. T. L., & Lima, B. C. (2018). Principais alterações fisiológicas decorrentes da obesidade: um estudo teórico. SANARE, 17, 56-65.
Loureiro, L. M. R. (2020). Efeito do café na recuperação do glicogênio muscular no pós-treino de ciclismo (Dissertation). Universidade de Brasília. 103p.
Matsudo, S., Araújo, T., Matsudo, V., Andrade, D., Andrade, E., Oliveira, L. C., & Braggion, G. (2012). Questionário internacional de atividade física (IPAQ): estudo de validade e reprodutibilidade no Brasil. Revista Brasileira de Atividade Física & Saúde, 6, 5-18.
Neeland, I. J., Ayers, C. R., Rohatgi, A. K., Turer, A. T., Berry, J. D., Das, S. R., Vega, G. L., Khera, A., McGuire, D. K., Grundy, S. M., & de Lemos, J. A. (2013). Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring), 21(9), E439-E447. https://doi.org/10.1002/oby.20135.
Neeland, I. J., Turer, A. T., Ayers, C. R., PowelL-Wiley, T. M., Vega, G. L., Farzaneh-Far, R., Grundy, S. M., Khera, A., McGuire, D. K., & de Lemos, J. A. (2012). Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA, 308(11), 1150. https://doi.org/10.1001/2012.jama.11132.
Paiva, C. L. R. S. (2018). Efeitos do café sobre a concentração sérica de hormônios Incretínicos e peptídeo c: ensaio clínico cruzado randomizado com isótopos estáveis (Master’s thesis). Universidade de Brasilia. 129p.
Passos, L. M. N., & Park, I. K. (2003). Frutooligossacarídeos: implicações na saúde humana e utilização em alimentos. Ciência Rural, 33, 385-390. https://doi.org/10.1590/S0103-84782003000200034.
Pérez-Pevida, B., Núñez-Córdoba, J. M., Romero, S., Miras, A. D., Ibañez, P., Vila, N., Margall, M. Á., Silva, C., Salvador, J., Frühbeck, G., & Escalada, J. (2019). Discriminatory ability of anthropometric measurements of central fat distribution for prediction of post-prandial hyperglycaemia in patients with normal fasting glucose: The DICAMANO Study. Journal of Translational Medicine, 17(1), 48-59. https://doi.org/10.1186/s12967-019-1787-5.
Poole, R., Kennedy, O. J., Roderick, P., Fallowfield, J. A., Hayes, P. C., & Parkes, J. (2017). Coffee consumption and health: Umbrella review of meta-analyses of multiple health outcomes. BMJ, j5024. https://doi.org/10.1136/bmj.j5024.
Preis, S. R., Massaro, J. M., Hoffmann, U., D'agostino, S. R. R. B., Levy, D., Robins, S. J., Meigs, J. B., Vasan, R. S., O'Donnell, C. J., & Fox, C. S. (2010). Neck circumference as a novel measure of cardiometabolic risk: The Framingham Heart Study. Journal of Clinical Endocrinology and Metabolism, 95(8), 3701-3710. https://doi.org/10.1210/jc.2009-1779.
Ribeiro, A. C., Sávio, K. E. O., Rodrigues, M. L. C. F., Costa, T. H. M., & Schmitz, B. A. S. (2006). Validation of a food frequency questionnaire for the adult population. Revista de Nutrição, 19, 553-562. https://doi.org/10.1590/S1415-52732006000500003.
Ried, K., Sullivan, T., Fakler, F. O. R., & Stocks, N. P. (2010). Does chocolate reduce blood pressure? A meta-analysis. BMC Medicine, 8(1), 39-50. https://doi.org/10.1186/1741-7015-8-39.
Saad, S. M. I., Cruz, A. G., & Faria, A. F. (2011). Probióticos e prebióticos em alimentos: fundamentos e aplicações tecnológicas [Probiotics and prebiotics in foods: Fundamentals and technological applications]. São Paulo, Varela.
Saeed, M., Naveed, M., Bibi, J., Kamboh, A. A., Phil, L., & Chao, S. (2019). Potential nutraceutical and food additive properties and risks of coffee: A comprehensive overview. Critical Reviews in Food Science and Nutrition, 59(20), 3293-3319. https://doi.org/10.1080/10408398.2018.1489368.
Saldanha, L. A. (2012). Efeitos da ingestão de cafeína, café (Coffea arabica) e chá mate (Ilex paraguariensis) sobre a atividade lipolítica do tecido adiposo e parâmetros metabólicos em ratos submetidos ao exercício físico. Faculdade de Saúde Pública, Universidade de São Paulo, 51p.
Santos, R. M. M., & Lima, D. R. A. (2016). Coffee consumption, obesity and type 2 diabetes: A mini-review. European Journal of Nutrition, 55, 1345-1358. https://doi.org/10.1007/s00394-016-1206-0.
Shearer, J., & Graham, T. E. (2014). Performance effects and metabolic consequences of caffeine and caffeinated energy drink consumption on glucose disposal. Nutrition Reviews, 72, 121-136. https://doi.org/10.1111/nure.12124.
Shi, X., Xue, W., Liang, S., Zhao, J., & Zhang, X. (2016). Acute caffeine ingestion reduces insulin sensitivity in healthy subjects: A systematic review and meta-analysis. Nutrition Journal, 15(1), 103-110. https://doi.org/10.1186/s12937-016-0220-7.
Silva, D. C. F., Nascimento, M. A. & Moreira, A. V. B. (2007). A Verificação da presença de compostos fenólicos com propriedades antioxidantes em amostras de café. Nutrire: Revista da Sociedade Brasileira de Alimentação e Nutrição, 32, 41-58.
Smith, C., & Essop, M. F. (2009). Gender differences in metabolic risk factor prevalence in a South African student population. Cardiovascular Journal of Africa, 20, 178-182.
Sociedade Brasileira de Cardiologia. (2016). VII Brazilian guidelines on arterial hypertension.
Sociedade Brasileira de Diabetes. (2018). Diretrizes Sociedade Brasileira de Diabetes.
Thom, E. (2007). The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. Journal of International Medical Research, 35(6), 900-908. https://doi.org/10.1177/147323000703500620.
Trabal, J., & Farran-Codina, A. (2015). Effects of dietary enrichment with conventional foods on energy and protein intake in older adults: A systematic review. Nutrition Reviews, 73(9), 624-633. https://doi.org/10.1093/nutrit/nuv023.
Wedick, N. M., Brennan, A. M., Sun, Q., Hu, F. B., Mantzoros, C. S., & van Dam, R. M. (2011). Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: A randomized controlled trial. Nutrition Journal, 10(1), 93-101. https://doi.org/10.1186/1475-2891-10-93.
Zaharieva, D. P., & Riddell, M. C. (2013). Caffeine and glucose homeostasis during rest and exercise in diabetes mellitus. Applied Physiology, Nutrition and Metabolism, 38(8), 813-822. https://doi.org/10.1139/apnm-2012-0471.

421316/2018-7 Brazilian National Council for Scientific and Technological Development (CNPq)

Keywords: body composition; cacao; caffeine; coffee; glycemic control

0 (Blood Glucose)
0 (Coffee)
0 (Oligosaccharides)
3G6A5W338E (Caffeine)

Date Created: 20220122 Date Completed: 20220519 Latest Revision: 20220617

20250114

10.1111/jfbc.14081

35064574